chr16-81889177-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_002661.5(PLCG2):​c.771T>C​(p.His257His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000401 in 1,587,818 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00090 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00035 ( 3 hom. )

Consequence

PLCG2
NM_002661.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -3.98

Publications

3 publications found
Variant links:
Genes affected
PLCG2 (HGNC:9066): (phospholipase C gamma 2) The protein encoded by this gene is a transmembrane signaling enzyme that catalyzes the conversion of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate to 1D-myo-inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) using calcium as a cofactor. IP3 and DAG are second messenger molecules important for transmitting signals from growth factor receptors and immune system receptors across the cell membrane. Mutations in this gene have been found in autoinflammation, antibody deficiency, and immune dysregulation syndrome and familial cold autoinflammatory syndrome 3. [provided by RefSeq, Mar 2014]
PLCG2 Gene-Disease associations (from GenCC):
  • autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • familial cold autoinflammatory syndrome 3
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-81889177-T-C is Benign according to our data. Variant chr16-81889177-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 540125.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.98 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000901 (136/150874) while in subpopulation AMR AF = 0.00614 (92/14992). AF 95% confidence interval is 0.00512. There are 0 homozygotes in GnomAd4. There are 75 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 136 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCG2NM_002661.5 linkc.771T>C p.His257His synonymous_variant Exon 10 of 33 ENST00000564138.6 NP_002652.2 P16885
PLCG2NM_001425749.1 linkc.771T>C p.His257His synonymous_variant Exon 11 of 34 NP_001412678.1
PLCG2NM_001425750.1 linkc.771T>C p.His257His synonymous_variant Exon 10 of 33 NP_001412679.1
PLCG2NM_001425751.1 linkc.771T>C p.His257His synonymous_variant Exon 11 of 34 NP_001412680.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCG2ENST00000564138.6 linkc.771T>C p.His257His synonymous_variant Exon 10 of 33 1 NM_002661.5 ENSP00000482457.1 P16885

Frequencies

GnomAD3 genomes
AF:
0.000902
AC:
136
AN:
150756
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000171
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00614
Gnomad ASJ
AF:
0.000867
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000354
Gnomad OTH
AF:
0.00388
GnomAD2 exomes
AF:
0.000650
AC:
154
AN:
236838
AF XY:
0.000609
show subpopulations
Gnomad AFR exome
AF:
0.000139
Gnomad AMR exome
AF:
0.00209
Gnomad ASJ exome
AF:
0.00248
Gnomad EAS exome
AF:
0.000170
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000402
Gnomad OTH exome
AF:
0.00171
GnomAD4 exome
AF:
0.000348
AC:
500
AN:
1436944
Hom.:
3
Cov.:
27
AF XY:
0.000348
AC XY:
249
AN XY:
715166
show subpopulations
African (AFR)
AF:
0.0000905
AC:
3
AN:
33140
American (AMR)
AF:
0.00247
AC:
108
AN:
43676
Ashkenazi Jewish (ASJ)
AF:
0.00218
AC:
56
AN:
25728
East Asian (EAS)
AF:
0.0000758
AC:
3
AN:
39560
South Asian (SAS)
AF:
0.000107
AC:
9
AN:
83944
European-Finnish (FIN)
AF:
0.0000567
AC:
3
AN:
52940
Middle Eastern (MID)
AF:
0.00315
AC:
18
AN:
5718
European-Non Finnish (NFE)
AF:
0.000218
AC:
238
AN:
1092708
Other (OTH)
AF:
0.00104
AC:
62
AN:
59530
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000901
AC:
136
AN:
150874
Hom.:
0
Cov.:
31
AF XY:
0.00102
AC XY:
75
AN XY:
73590
show subpopulations
African (AFR)
AF:
0.000170
AC:
7
AN:
41114
American (AMR)
AF:
0.00614
AC:
92
AN:
14992
Ashkenazi Jewish (ASJ)
AF:
0.000867
AC:
3
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5098
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4598
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10468
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000354
AC:
24
AN:
67856
Other (OTH)
AF:
0.00384
AC:
8
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000621
Hom.:
0
Bravo
AF:
0.00155

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Nov 15, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PLCG2: BP4, BP7 -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

PLCG2-related disorder Benign:1
Jun 12, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Familial cold autoinflammatory syndrome 3 Benign:1
Jan 17, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.072
DANN
Benign
0.64
PhyloP100
-4.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs369555285; hg19: chr16-81922782; COSMIC: COSV63875117; COSMIC: COSV63875117; API